The 244.1% trailing 1-year return represents a complete structural shift in investor sentiment, moving Intel from a value-trap narrative to a high-growth turnaround play that has effectively tripled the performance of the broader market during its recovery phase.
The 5-year annualized return of 0.9% serves as a critical warning that Intel is prone to extended periods of stagnation; investors must monitor the 'five nodes in four years' roadmap closely, as any execution slip-up could see the stock return to the lackluster performance levels seen between 2018 and 2023.
The primary concern is the divergence between the 80.4 RSI and the marginal 0.81% increase in institutional ownership, which suggests that the recent price surge lacks the heavy-weight backing required for a sustained breakout. If institutions do not significantly increase their 65.95% stake during the next earnings cycle, the stock is at risk of a sharp 15-20% correction as retail momentum fades and the RSI mean-reverts toward 50.
Intel's massive R&D intensity of 26.1% relative to a declining 3-year revenue CAGR of -5.7% highlights a critical transition phase where the company is sacrificing the balance sheet to bridge a widening technological gap. This level of spending is essential for the IDM 2.0 turnaround but creates a high-risk profile until these investments translate into competitive foundry volumes and market share gains.
The -9.4% FCF margin represents a dangerous disconnect between operational cash generation and the capital expenditures required for the foundry transition. If revenue does not scale quickly to fill new capacity, the continued cash burn could necessitate further dividend cuts or dilutive capital raises to maintain the $52.9B revenue infrastructure.
The transition from a 20.6% net margin to a -0.5% loss highlights the severe 'operating leverage' risk Intel faces; as revenue stagnates, the massive fixed costs of its manufacturing footprint are now actively eroding shareholder equity rather than scaling it.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -0.2 | -0.5 | 0.25 | 1.85 | -1.3 | -0.0 | -0.1 |
| 2024 | -18.9 | -35.3 | 0.27 | 1.98 | -7.9 | -7.3 | -9.5 |
| 2023 | 1.6 | 3.1 | 0.28 | 1.81 | 0.1 | 0.1 | 0.9 |
| 2022 | 7.9 | 12.7 | 0.35 | 1.80 | 1.8 | 1.6 | 4.4 |
| 2021 | 20.8 | 25.1 | 0.47 | 1.77 | 15.2 | 13.8 | 11.8 |
| 2020 | 25.8 | 26.8 | 0.51 | 1.89 | 20.6 | 18.4 | 13.7 |
| 2019 | 27.2 | 29.2 | 0.53 | 1.76 | 21.7 | 19.3 | 15.4 |
| 2018 | 28.2 | 29.7 | 0.55 | 1.72 | 23.9 | 20.9 | 16.5 |
| 2017 | 13.9 | 15.3 | 0.51 | 1.79 | 20.0 | 17.1 | 7.8 |
| 2016 | 15.6 | 17.4 | 0.52 | 1.71 | 17.5 | 14.1 | 9.1 |
| 2015 | 18.7 | 20.6 | 0.54 | 1.69 | 19.5 | 16.0 | 11.1 |
The combination of a negative ROIC and a rising Equity Multiplier (1.85) is a critical risk, as it suggests Intel is leveraging its balance sheet to fund value-destructive investments, potentially leading to a credit rating downgrade if fab yields do not improve by 2025.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1460 | 123 | 27 | 728 | 105 | 45 |
| 2024 | 1351 | 125 | 24 | 742 | 128 | 20 |
| 2023 | 1289 | 125 | 23 | 654 | 96 | 52 |
| 2022 | 1054 | 133 | 24 | 468 | 97 | 61 |
| 2021 | 778 | 112 | 44 | 292 | 60 | 96 |
| 2020 | 718 | 90 | 32 | 265 | 59 | 62 |
| 2019 | 692 | 107 | 39 | 281 | 51 | 95 |
| 2018 | 659 | 98 | 35 | 252 | 51 | 81 |
| 2017 | 717 | 108 | 33 | 239 | 45 | 95 |
| 2016 | 697 | 87 | 29 | 222 | 39 | 77 |
| 2015 | 680 | 91 | 32 | 210 | 36 | 86 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $211429M | $85069M | $114281M | $46585M | $32320M | $14265M | $63688M | $31575M |
| 2024 | $196485M | $91453M | $99270M | $50011M | $41762M | $8249M | $47324M | $35666M |
| 2023 | $191572M | $81607M | $105590M | $49278M | $42199M | $7079M | $43269M | $28053M |
| 2022 | $182103M | $78817M | $101423M | $42051M | $30907M | $11144M | $50407M | $32155M |
| 2021 | $168406M | $73015M | $95391M | $38101M | $33274M | $4827M | $57718M | $27462M |
| 2020 | $153091M | $72053M | $81038M | $36401M | $30536M | $5865M | $47249M | $24754M |
| 2019 | $136524M | $59020M | $77504M | $29001M | $24807M | $4194M | $31239M | $22310M |
| 2018 | $127963M | $53400M | $74563M | $26359M | $23340M | $3019M | $28787M | $16626M |
| 2017 | $123249M | $54230M | $69019M | $26813M | $23380M | $3433M | $29500M | $17421M |
| 2016 | $113327M | $47101M | $66226M | $25283M | $19723M | $5560M | $35508M | $20302M |
| 2015 | $103065M | $41980M | $61085M | $22670M | $7362M | $15308M | $40356M | $15667M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $9697M | $-14821M | $11587M | $-14646M | $-4949M | ||
| 2024 | $8288M | $-18256M | $11138M | $-23944M | $-15656M | $-1599M | |
| 2023 | $11471M | $-24041M | $8505M | $-25750M | $-14279M | $-3088M | |
| 2022 | $15433M | $-10231M | $1115M | $-25050M | $-9617M | $-5997M | |
| 2021 | $29456M | $-24283M | $-6211M | $-20329M | $9127M | $-2415M | $-5644M |
| 2020 | $35384M | $-20796M | $-12917M | $-14453M | $20931M | $-14229M | $-5568M |
| 2019 | $33145M | $-14405M | $-17565M | $-16213M | $16932M | $-13576M | $-5576M |
| 2018 | $29432M | $-11239M | $-18607M | $-15181M | $14251M | $-10730M | $-5541M |
| 2017 | $22110M | $-15762M | $-8475M | $-11778M | $10332M | $-3615M | $-5072M |
| 2016 | $21808M | $-25817M | $-5739M | $-9625M | $12183M | $-2587M | $-4925M |
| 2015 | $19017M | $-8183M | $1912M | $-7446M | $11571M | $-3001M | $-4556M |